|
End-of-day quote
Shanghai S.E.
20/10/2026
|
5-day change | 1st Jan Change | ||
| 14.11 CNY | -1.95% |
|
+1.00% | -6.37% |
| 15/10 | Huachuang Securities Starts Tasly Pharmaceutical Group at Add with 17.20 Yuan Price Target | MT |
| 15/10 | Tasly Pharmaceutical Wins Clinical Trial Approval for TDX105 Granules | MT |
| Market Cap | 2.11TCr 315.57Cr 280.89Cr 260.33Cr 235.9Cr 443.34Cr 30TCr 450.76Cr 3.12TCr 1.23TCr 16TCr 1.18TCr 1.16TCr 50TCr | P/E 2026 * |
15.8x | P/E 2027 * | 13.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.95TCr 292.46Cr 260.32Cr 241.26Cr 218.62Cr 410.87Cr 28TCr 417.75Cr 2.89TCr 1.14TCr 14TCr 1.1TCr 1.07TCr 46TCr | EV / Sales 2026 * |
2.26x | EV / Sales 2027 * | 1.64x |
| Free-Float |
47.11% | Yield 2026 * |
2.75% | Yield 2027 * | 3.34% |
| 1 day | -1.95% | ||
| 1 week | +1.00% | ||
| Current month | +0.79% | ||
| 1 month | +1.80% | ||
| 3 months | -12.14% | ||
| 6 months | -0.35% | ||
| Current year | -6.37% |
| 1 week | 13.92 |  | 14.44 |
| 1 month | 13.64 | | 14.44 |
| Current year | 12.9 | | 16.24 |
| 1 year | 12.9 | | 16.24 |
| 3 years | 12.24 | | 18 |
| 5 years | 9.2 | | 18 |
| 10 years | 9.2 | | 34.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Yong Cai
CEO | Chief Executive Officer | 54 | 08/05/2024 |
Jie Wei
DFI | Director of Finance/CFO | 49 | 09/07/2018 |
Xin Yang
CIO | Chief Investment Officer | 45 | 01/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ai Jian Wang
BRD | Director/Board Member | 72 | 02/06/2021 |
Jin Yong Cai
CHM | Chairman | 54 | 10/08/2026 |
Ke Xin Li
BRD | Director/Board Member | 58 | 08/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.95% | +1.00% | -11.26% | +5.22% | 315.57Cr | |
| +3.49% | +10.04% | +58.68% | +119.56% | 1,14400Cr | |
| +2.19% | +4.32% | +33.88% | +69.52% | 63TCr | |
| +2.26% | +5.37% | +24.57% | +97.69% | 51TCr | |
| +0.14% | +5.23% | +39.00% | +64.30% | 38TCr | |
| +3.25% | +4.45% | +71.80% | +44.44% | 37TCr | |
| +0.22% | +3.39% | +21.29% | +50.08% | 29TCr | |
| +0.01% | +2.50% | +1.07% | +24.82% | 26TCr | |
| +3.29% | +6.32% | +44.71% | +57.43% | 24TCr | |
| +2.25% | +5.81% | +27.13% | +101.17% | 19TCr | |
| Average | +0.83% | +5.56% | +31.09% | +63.42% | 40.11TCr | |
| Weighted average by Cap. | +0.61% | +6.90% | +40.93% | +81.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 863.35Cr 129.25Cr 115.04Cr 106.62Cr 97Cr 181.58Cr 12TCr 184.62Cr 1.28TCr 502.59Cr 6.41TCr 484.81Cr 474.75Cr 20TCr | 935.65Cr 140.07Cr 124.68Cr 115.55Cr 104.71Cr 196.78Cr 13TCr 200.08Cr 1.39TCr 544.68Cr 6.94TCr 525.41Cr 514.51Cr 22TCr |
| Net income | 133.73Cr 20Cr 18Cr 17Cr 15Cr 28Cr 1.9TCr 29Cr 198.16Cr 78Cr 992.47Cr 75Cr 74Cr 3.17TCr | 158.04Cr 24Cr 21Cr 20Cr 18Cr 33Cr 2.24TCr 34Cr 234.19Cr 92Cr 1.17TCr 89Cr 87Cr 3.74TCr |
| Net Debt | -154.39Cr -23Cr -21Cr -19Cr -17Cr -32Cr -2.19TCr -33Cr -228.78Cr -90Cr -1.15TCr -87Cr -85Cr -3.66TCr | -571.22Cr -86Cr -76Cr -71Cr -64Cr -120.14Cr -8.1TCr -122.15Cr -846.47Cr -332.53Cr -4.24TCr -320.76Cr -314.11Cr -14TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | CN¥14.11 | -1.95% | 1,43,18,542 |
| 19/26/19 | CN¥14.39 | +2.49% | 1,56,61,403 |
| 16/26/16 | CN¥14.04 | -0.35% | 1,57,18,760 |
| 15/26/15 | CN¥14.09 | -1.33% | 1,54,05,764 |
| 14/26/14 | CN¥14.28 | +2.22% | 1,54,73,462 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600535 Stock
Select your edition
All financial news and data tailored to specific country editions
